Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2023

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages). Prior period amounts have been restated at constant currency to conform to current year presentation.


	Three Months Ended June 30,				Six Months Ended June 30,
Net Sales	2023		2022		2023		2022
MedSurg	$	1,331	$	1,217	$	2,582	$	2,322
Cardiovascular	2,179		1,926		4,228		3,695
Total net sales of reportable segments	3,509		3,143		6,810		6,016


Impact of foreign currency fluctuations	91		101		179		254
	$	3,599	$	3,244	$	6,988	$	6,270



Income (loss) before income taxes
MedSurg	$	448	$	359	$	847	$	689
Cardiovascular	566		454		1,106		843
Total operating income of reportable segments	1,013		812		1,954		1,531
Unallocated amounts:
Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments	(49)		6		(124)		68
Goodwill and intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU MDR implementation costs	(241)		(192)		(351)		(308)
Amortization expense	(210)		(204)		(412)		(402)

Operating income (loss)	514		423		1,066		889
Other expense, net	(88)		(78)		(195)		(388)
Income (loss) before income taxes	$	426	$	345	$	870	$	501


	Three Months Ended June 30,				Six Months Ended June 30,
Operating income margin of reportable segments	2023		2022		2023		2022
MedSurg	33.6	%	29.5	%	32.8	%	29.7	%
Cardiovascular	26.0	%	23.6	%	26.2	%	22.8	%